Phase II clinical trial comparing efficacy of low nicotine cigarettes (X-22) with varenicline and nicotine replacement therapies (patches, lozenges)

Trial Profile

Phase II clinical trial comparing efficacy of low nicotine cigarettes (X-22) with varenicline and nicotine replacement therapies (patches, lozenges)

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Jun 2015

At a glance

  • Drugs Nicotine (Primary) ; Nicotine replacement therapy; Varenicline
  • Indications Smoking withdrawal
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 22 Jun 2015 New trial record
    • 17 Jun 2015 Results published in a 22nd Century Group Media Release.
    • 17 Jun 2015 As per a 22nd Century Group media release, data from this study has been accepted by Nicotine and Tobacco research for publication.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top